(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.On march 14, 2017, abbott vascular decided to initiate a voluntary field action for some sizes and lots of the nc trek family of dilatation catheters for difficulty to remove sheath which may lead to inflation or deflation issues.[medwatch # 2024168-2017-02310].
|
It was reported that a 3.75x15mm nc trek dilatation catheter advanced to the mid right coronary artery (rca), moderately calcified lesion without issue.Balloon inflation was attempted; however, the balloon failed to inflate to nominal diameter at 12 atmospheres (atms).The balloon was only able to partially inflate.The device was removed without issue and another device was used in replacement with satisfactory results.There were no adverse patient effects and there was no clinically significant procedural delay.There was no additional information provided regarding this device issue.
|
(b)(4).Evaluation summary: the device returned for analysis.The complaint investigation determined the reported issue to be related to manufacturing issues associated with the protective sheath.On march 14, 2017, abbott vascular decided to initiate a voluntary field action for some sizes and lots of the nc trek family of dilatation catheters for difficulty to remove sheath which may lead to inflation or deflation issues.Abbott vascular performed a comprehensive investigation which included device analysis, manufacturing evaluation and trend analysis.The root cause identification was complicated by the fact that users were describing multiple symptoms when reporting the complaints.To date, the frequency of worldwide reported events for difficulties removing the protective balloon sheath, inflation and deflation has reached an actionable limit, thus abbott vascular communicated the voluntary field action to the fda on march 17, 2017 [medwatch # 2024168-2017-02310].Corrective action has been implemented per site operating procedures.The product will continue to be trended.The abbott internal recall number is 2024168-3/14/2017-002-r.
|